Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Anthony Scaramucci Shares Mike Novogratz’s Advice That If You Have $50K–$200K, Don’t ‘YOLO’ It—Stick To Index Funds, Long-Term Investing

by Ananya Gairola | Feb 25, 2026 | General

On Tuesday, SkyBridge Capital founder Anthony Scaramucci highlighted advice from Mike Novogratz, CEO of Galaxy Digital, urging investors with modest savings to avoid risky bets and focus on long-term, diversified investing instead. Mike Novogratz Warns Against YOLO...
Novo Nordisk To Slash GLP-1 Drug Prices By Up To 50% In US Starting 2027

Novo Nordisk To Slash GLP-1 Drug Prices By Up To 50% In US Starting 2027

by Namrata Sen | Feb 25, 2026 | General

Novo Nordisk A/S (NYSE:NVO) announced plans on Tuesday to cut the list prices of its GLP-1 drugs by up to 50% in the U.S. starting in 2027. The price reduction will affect the obesity injection Wegovy, its pill counterpart, the diabetes shot Ozempic, and the oral...

Scott Bessent Sidesteps $134 Billion Tariff Refund Question, Calls Corporate Lawsuits ‘Ultimate Corporate Welfare’

by Rishabh Mishra | Feb 25, 2026 | General

Treasury Secretary Scott Bessent refused to commit to issuing $134 billion in potential tariff refunds during a post-State of the Union interview, instead framing corporate demands for repayment as a form of government handout. The Refund Standoff Following President...

Gita Gopinath Says 150-Day Tariffs ‘Cannot Reduce Persistent Trade Deficits,’ Rejects ‘Heart Attack’ Narratives For US Economy

by Rishabh Mishra | Feb 25, 2026 | General

Harvard Professor and former IMF First Deputy Managing Director Gita Gopinath has dismissed claims that the U.S. is facing a balance-of-payments (BoP) crisis, arguing that the administration’s new 150-day tariffs are an ineffective tool for long-term economic...
What Sparked AbCellera Biologics To Soar Over 9% After Hours

What Sparked AbCellera Biologics To Soar Over 9% After Hours

by Mohd Haider | Feb 25, 2026 | General

AbCellera Biologics Inc. (NASDAQ:ABCL) shares are trending on Wednesday. Earnings Beat Drives After-Hours Rally Shares of the Vancouver-based biotechnology company rose 9.32% in after-hours trading on Tuesday to $3.52 after the company reported its fourth-quarter 2025...
« Older Entries
Next Entries »

Recent Posts

  • Venture Global First Korean Deal Marks New LNG Era
  • If You Invested $100 In AstraZeneca Stock 5 Years Ago, You Would Have This Much Today
  • Caesars Entertainment Stock Maintains Momentum: What’s Next?
  • $1000 Invested In Fidelity Nasdaq Composite Index ETF 10 Years Ago Would Be Worth This Much Today
  • Grant Cardone To Tokenize $5B Of Real Estate, But XRP Is Not On His Partner Shortlist

Recent Comments

    Archives

    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.